Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Share
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Gail wants to know whether a 529 or whole life insurance policy is the best way to save money for her grandson’s college education.
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Key catalysts for bitcoin, with CNBC’s Seema Mody and the Futures Now traders, Jim Iuorio and Scott Nations, both at the CME. 02:48 Tue, Sep 24 20191:57 PM EDT
Suze Orman offers a behind the scenes look at her show.
CNBC’s Jim Cramer said Federal Trade Commission chair Lina Khan’s attempts to stop mergers and acquisitions from going through is hurting stock portfolios in the process. “Khan’s FTC has deterred many a potential merger, and that’s kept stock valuations much lower than they should be, as the Nippon Steel-U.S. Steel deal shows,” Cramer said Monday….
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Investors seem to be expecting a “massive” stimulus from the Democratic sweep of Congress, according to Jim Lowell, CIO of Adviser Investments. 00:00 Fri, Jan 8 20212:43 AM EST
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Adena Friedman, Nasdaq CEO, joins ‘Closing Bell Overtime’ to talk possible IPOs in 2024, market volatility, AI investing and more. 06:57 Wed, Jan 10 20245:27 PM EST